An ever-expanding area of collaboration is occurring between patients, patient organizations, industry, regulators, and governmental organizations to ensure that new drugs developed both represent value to the patients they aim to treat, and that the timeframe for providing new innovations to patients is accelerated. Integrating the patient experience from the early stages of drug development through approval and post-marketing is now an accepted norm. However, for many companies, understanding why this is important as well as convincing leadership to invest in these activities can be confusing and elusive. These courses provide fundamentals about why and how to build such a function.

This module is designed to provide the foundational knowledge for integrating the patient perspective into the full medicines lifecycle, including regulatory decision making and post-marketing efforts, which can improve patient outcomes and increase the success of the product. The concepts covered in this course apply to drugs, biologics, devices, and any medical/therapeutic products developed for patient use.

This module takes an average of 1 hour to complete.

This module is part of the DIA Patient Engagement eLearning Program and a component of the Patient Engagement Certificate Program.